ONO-5788
Sponsors
Ono Pharmaceutical Co. Ltd
Conditions
Acromegaly
Phase 1
A Four-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-5788 in Healthy Adult Volunteers
TerminatedNCT03571594
Start: 2018-06-07End: 2019-05-16Updated: 2019-06-05
Single-dose Study to Evaluate the Absolute Bioavailability and Mass Balance of ONO-5788
CompletedNCT03849872
Start: 2019-02-27End: 2019-04-02Updated: 2019-11-07